LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | SNS-032 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 4651 | 5505 | 0.8449 | 0.7781 |
BT-20 | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5881 | 5505 | 1.0682 | 1.0975 |
BT-20 | PI103 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5425 | 5505 | 0.9854 | 0.9790 |
BT-20 | QL-XII-47 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 4749 | 5505 | 0.8627 | 0.8035 |
BT-20 | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 4885 | 5505 | 0.8874 | 0.8389 |
BT-20 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5828 | 5505 | 1.0587 | 1.0839 |
BT-20 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2584 | 5505 | 0.4695 | 0.2409 |
BT-20 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 1217 | 5505 | 0.2211 | -0.1145 |
BT-20 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5553 | 5505 | 1.0087 | 1.0124 |
BT-20 | KIN001-043 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5295 | 5505 | 0.9618 | 0.9453 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 1613 | 5505 | 0.2930 | -0.0116 |
BT-20 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5115 | 5505 | 0.9291 | 0.8986 |
BT-20 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 4635 | 5505 | 0.8420 | 0.7739 |
BT-20 | AZD 5438 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5047 | 5505 | 0.9167 | 0.8808 |
BT-20 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2745 | 5505 | 0.4986 | 0.2826 |
BT-20 | A443654 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2897 | 5505 | 0.5262 | 0.3221 |
BT-20 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5888 | 5505 | 1.0694 | 1.0994 |
BT-20 | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5567 | 5505 | 1.0111 | 1.0159 |
BT-20 | BI-2536 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 1491 | 5505 | 0.2709 | -0.0432 |
BT-20 | R406 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5812 | 5505 | 1.0556 | 1.0796 |
BT-20 | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 4409 | 5505 | 0.8009 | 0.7151 |
BT-20 | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5762 | 5505 | 1.0466 | 1.0667 |
BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5824 | 5505 | 1.0578 | 1.0827 |
BT-20 | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2703 | 5505 | 0.4910 | 0.2716 |
BT-20 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1657 | 3525 | 5505 | 0.6404 | 0.4854 |